Replies to post #16883 on Intellipharmaceutics International Inc. (IPCI)

[InTheTrenches]

My best guess is that the NDA is all set to go, except revealing the name of the contract manufacturer or partner/manufacturer.

My read of the 505(b)(2) NDA is that a manufacturer name/address must be explicitly stated in the NDA.

Therefore, I think IPCI is reviewing proposals for a contract manufacturer verses a full partner (marketing and manufacturing), trying to decide the best path forward for shareholders.

If you look at ELTP, who also filed a 505(b)(2) NDA, they had a contract manufacturing agreement before filing their NDA.

I think (hope) we're close.